Searched for
DIAGNOSTICS CHAIN TRANSACTION
PE wars to billion-dollar IPO dreams, hospital sector is fighting fitMajor private equity firms are vying for a stake in Cloudnine, a leading maternity and paediatric care chain. This intense competition high...- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsFor the next few weeks, what needs to be watched is market breadth. And also look at which sectors are leading the rally. Why? Because, at ...
- Siemens eyes exit from cancer care chain American Oncology InstituteSiemens Healthineers is exiting its Indian cancer care chain, American Oncology Institute. The deal is valued between ₹1,500-2,000 crore. P...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%We are living in times when the morning may see conciliatory exchanges between the US and Iran, leading to a cooling in crude oil prices. B...
- ET Prime Special Series: Multibagger or Bankrupt - Part 56: An acquisition, a divestment, and a JV for EV. Ready for re-rating?Bulls argue this company is becoming a complete mobility-platform supplier in India: Power solutions and aftermarket, braking and safety. B...
- India to attract major share of EQT's $15.6-billion Asia fund: EQT India headEQT expects India to remain a top capital destination in its new Asia fund, with roughly one-third allocation historically. The firm sees s...
- Fortis Healthcare gets CCI nod to acquire additional stake in Agilus Diagnostics for Rs 1,780 crThe Competition Commission of India (CCI) has approved Fortis Healthcare's acquisition of an additional 31.52% stake in Agilus Diagnostics,...
- GSK Velu in talks with investors, PEs & banking firms to buy Metropolis Healthcare stakeMetropolis chief executive Ameera Shah and her family has initiated a formal process to sell part of the promoter stake and is understood t...
- Motilal Oswal Private Equity invests RS 194.4 crore in Pathkind DiagnosticsEstablished in 2016, Pathkind is one of the fastest growing diagnostics services chains in India with a network of over 75 labs of which 13...
- Amazon, Walmart's Flipkart in talks to buy stake in $1.1 billion diagnostics chain Metropolis HealthcareThe company is in early discussions with several global strategic investors and other potential purchasers of the shares, said the people, ...
- Metropolis Healthcare up 0.7% as board approves acquisition of Hitech DiagnosticMetropolis Healthcare said the deal would be worth Rs 636 crore.
- Diagnostics chain HealthMaP looks at merger with iGeneticUnder the proposed deal, HealthMap will get access to iGenetic’s core markets in Mumbai and other profit-making regions. “The idea is to me...
- Constellation Alpha to acquire pathology chain Medall HealthcareConstellation was formed as a public platform for acquiring Indian healthcare businesses. Constellation raised $144 million in its initial ...
- OrbiMed to invest $40 million in Suraksha DiagnosticsSuraksha, promoted by Panorama Group, operates more than 30 centres including polyclinics and has expanded services to include cardiology ,...
- Carlyle to buy 37% stake in diagnostics chain MetropolisGlobal private equity fund Carlyle is buying 37% stake in diagnostics chain Metropolis from one of its founders GSK Velu.
- Carlyle may end Metropolis feud with Rs 900 crore stake buyMetropolis s today a multinational chain with more than 125 laboratories, tracking Rs 600-crore revenue annually.
- Fortis to acquire 86% stake in Super Religare LaboratoriesBillionaire brothers Malvinder and Shivinder Singh are selling 86% stake in Super Religare Laboratories ahead of its public issue, to liste...
- Singh bros may buy Piramal’s 10% in SRL ahead of public issueThe promoters of Super Religare Laboratories Malvinder and Shivinder Singh may buyout Piramal Heathcare’s 10% stake in the country’s larges...
- US PE firm in talks to buy 15% in Dr Lal PathLabs from SequoiaUS-based private equity (PE) firm TA Associates is in advanced talks to buy half of Sequoia Capital’s 30% stake in the country’s largest di...
- SRL in talks to acquire Piramal DiagnosticsDiagnostic chain Super Religare Laboratories is in advanced talks to buy Piramal Healthcare’s diagnostic chain for up to Rs 800 crore.
Load More
